cancer

Julie Walters, Harry Potter and Mamma Mia! Actress, Reveals Cancer Diagnosis

Dame Julie Walters, the Academy-Award nominated actress best known as Molly Weasley from the Harry Potter films, has revealed that she was diagnosed with stage 3 bowel cancer in 2018. She has since received treatment and her cancer is in remission. Walters first learned of the diagnosis two years ago, but kept the news within her family until a recent interview with the BBC. She said she found it harder to tell her husband, Grant Roffey, about the cancer than to hear about it herself. “I’ll never forget his face,” she recalled. “Tears came into his eyes and I thought, ‘Oh, Grant!’ So then I’m worried about him more than [the diagnosis].” She began treatment by having “30cm taken out of my colon” — that’s about 12 inche...

First step in study shows CRISPR gene-edited cells are safe for use in cancer patients

This is the web version of Brainstorm Health Daily, Fortune’s daily newsletter on the top health care news. To get it delivered daily to your in-box, sign up here. Happy Thursday, readers! Cool science is intrinsically exciting. And the concept of slicing and dicing DNA through CRISPR gene-editing in order to treat conditions ranging from cancer to inherited disorders is ever-so-cool—on top of being a massive opportunity for investors and businesses, and, most importantly, potentially life-changing for patients (always good to keep them top of mind). But from the early days of the genomic revolution, there’s been a key question: are edited cells safe to use in humans? On Thursday, we got at least a little bit more information on the safety-side of this nascent biological tech—and it&...

GlaxoSmithKline Hopes to Take on Rivals With Rare Blood Cancer Drug

This is the web version of Brainstorm Health Daily, Fortune’s daily newsletter on the top health care news. To get it delivered daily to your in-box, sign up here. Good afternoon, readers! British drug giant GlaxoSmithKline is hoping to take on prominent rivals such as U.S.-based Johnson & Johnson with an experimental treatment for multiple myeloma, a rare blood cancer. GSK said that its multiple myeloma treatment belantamab mafodotin was effective in patients who had already received a half dozen (or even more) other therapies, suggesting it could be effective in those with the most stubborn forms of the disease. And the company is submitting it for Food and Drug Administration (FDA) approval. “Patients with multiple myeloma whose disease has progressed despite currently availab...

You’ve heard of CRISPR, now meet its newer, savvier cousin CRISPR Prime

CRISPR, the revolutionary ability to snip out and alter genes with scissor-like precision, has exploded in popularity over the last few years and is generally seen as the standalone wizard of modern gene-editing. However, it’s not a perfect system, sometimes cutting at the wrong place, not working as intended and leaving scientists scratching their heads. Well, now there’s a new, more exacting upgrade to CRISPR called Prime, with the ability to, in theory, snip out more than 90% of all genetic diseases. Just what is this new method and how does it work? We turned to IEEE fellow, biomedical researcher and dean of graduate education at Tuft University’s school of engineering Karen Panetta for an explanation. How does CRISPR Prime editing work? CRISPR is a powerful genome ed...

DevilDriver drop off tour with Static-X as frontman Dez Fafara’s wife battles cancer

DevilDriver have dropped off their upcoming fall co-headlining tour with Static-X after frontman Dez Fafara’s wife, Anahstasia, was diagnosed with cancer. Fafara revealed the news of his wife’s cancer battle earlier this month while announcing the band would not be playing Megadeth’s recently completed MegaCruise. In his initial social post, he wrote, “Today my world is black. My wife and best friend @mrsfafara was told yesterday she has cancer. Please send positive vibes for our family while we go through this difficult time.” And now it was just revealed that DevilDriver are pulling out of the Static-X tour, as well. Regarding that decision, Fafara stated: “Hello everyone, my wife has been diagnosed with cancer. I will be staying home to care for her and be ...

Beyoncé and Solange’s dad, Mathew Knowles, diagnosed with breast cancer

Mathew Knowles, the father of Beyoncé and Solange, has been diagnosed with breast cancer. The 67-year-old revealed the news during an interview with Good Morning America’s Michael Strahan that’s set to air on Wednesday (via TMZ). Breast cancer may be rare in males, but it’s not unheard of. Fewer than 1% of patients with the disease are men, with most of those being between the ages of 60 and 70. Unfortunately, the mortality rate for men is higher than women, according to the National Breast Cancer Foundation. (Read: Classic Album Review: The Writing Was Already on the Wall by Destiny’s Child’s Breakthrough) Knowles managed Beyoncé for much of her career, including her time in Destiny’s Child. Their professional relationship ended in 2011, the same year Mathew finalized hi...

Google’s SMILY is reverse image search for cancer diagnosis

Spotting and diagnosing cancer is a complex and difficult process even for the dedicated medical professionals who do it for a living. A new tool from Google researchers could improve the process by providing what amounts to reverse image search for suspicious or known cancerous cells. But it’s more than a simple matching algorithm. Part of the diagnosis process is often examining tissue samples under a microscope and looking for certain telltale signals or shapes that may indicate one or another form of cancer. This can be a long and arduous process because every cancer and every body is different, and the person inspecting the data must not only look at the patient’s cells but also compare them to known cancerous tissues from a database or even a printed book of samples. As h...

Paige details first AI pathology tech with clinical-grade accuracy in new research paper

Medical tech and computational pathology startup Paige has published a new article in the peer-reviewed medical journal Nature Medicine, detailing its artificial intelligence-based detection system for identifying prostate cancer, skin cancer and breast cancer, which the company says achieves “near-perfect accuracy.” Paige’s tech, which employs deep learning trained on a dataset of almost 45,000 slide images taken from over 15,000 patients spanning 44 countries, is novel in that it can eschew the need to curate data sets for training first, which greatly decreases cost and time required to build accurate AI-based diagnostic tools. Last February, Paige announced $25 million in Series A funding, and a partnership with Memorial Sloan Kettering Center (MSK) to gain access to ...